Form 4: Ingersoll Rand SVP Sells Shares Under 10b5-1 Plan
Insider Trading Report
Ingersoll Rand's Senior VP, Chief Human Resources Officer, Kathleen M. Keene, sold 12,000 shares of common stock for $99.46 per share under a pre-arranged 10b5-1 plan.
Summary
- Kathleen M. Keene, Senior Vice President and Chief Human Resources Officer of Ingersoll Rand Inc., reported a sale of company common stock.
- On February 17, 2026, Ms. Keene disposed of 12,000 shares of Ingersoll Rand Inc. common stock.
- The shares were sold at a price of $99.46 per share.
- Following this transaction, Ms. Keene beneficially owns 3,528 shares of common stock directly.
- The transaction was executed pursuant to a Rule 10b5-1(c) pre-arranged trading plan.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. While an insider sale reduces direct holdings, its execution under a 10b5-1 plan suggests a pre-planned diversification rather than a reaction to negative company-specific news, making it a routine occurrence.
Positives
- The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-scheduled sale rather than a reaction to recent company news, which can mitigate negative interpretations of insider selling.
Negatives
- An insider sale of 12,000 shares, reducing the beneficial ownership to 3,528 shares, represents a significant reduction in the insider's direct holdings.
- The sale by a Senior Vice President could be interpreted by some investors as a lack of confidence in the company's near-term stock performance, despite being part of a 10b5-1 plan.
Future Outlook
No forward-looking statements or guidance are provided in this Form 4 filing.
Industry Context
StockSavvy.ai notes that insider sales, even those executed under a Rule 10b5-1 plan, are routinely monitored by investors as they can offer insights into management's perspective on future stock performance. While a 10b5-1 plan indicates a pre-scheduled sale, it's still a reduction in insider holdings, which can be viewed differently compared to insider purchases, especially in the industrial manufacturing sector where long-term growth prospects are key.
Comparison to Industry Standards
- Insider selling activity is a common occurrence across all industries, including industrial manufacturing. For example, similar sales under 10b5-1 plans have been observed at peers like Honeywell International (HON) or Danaher Corporation (DHR), where executives periodically diversify their holdings.
- The significance of such a sale is often weighed against the executive's remaining stake and the overall insider sentiment within the company and sector. Without broader context of other insider transactions at Ingersoll Rand or its direct competitors, it is difficult to make a specific comparative assessment beyond noting it is a standard practice for executives to manage their equity compensation.
Stakeholder Impact
- Shareholders: May interpret the insider sale as a slight negative, though the 10b5-1 plan mitigates concerns about immediate insider sentiment. The reduction in direct holdings could be seen as a decrease in alignment, but the remaining stake still provides some alignment.
- Employees: No direct impact mentioned.
- Customers/Suppliers/Creditors: No direct impact mentioned.
Key Dates
| Date | Description |
|---|---|
| 02/17/2026 | Date of transaction (sale of common stock) |
| 02/19/2026 | Date the Form 4 was signed by the attorney-in-fact |
Recommendation
holdThe insider sale, while reducing the executive's direct holdings, was conducted under a pre-arranged 10b5-1 plan. This suggests a planned diversification of personal assets rather than a reaction to new, negative company information. As such, it is unlikely to significantly alter the fundamental investment thesis for Ingersoll Rand, warranting a 'hold' recommendation based solely on this filing.
Keywords
Ingersoll Rand, IR, Form 4, insider trading, stock sale, Kathleen M. Keene, 10b5-1 plan, beneficial ownership, corporate officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.